Chordate Medical Holding AB Sustainability Reports

Chordate Medical Holding AB is a medical technology company that develops, patents, and markets neuromodulation treatment technologies. Its primary product, Ozilia, provides drug-free treatment solutions for chronic migraine and chronic rhinitis.

Sector: Manufacturing

Country: Sweden

Exchange: Nasdaq Stockholm

LEI: 549300R0GG2J3S0BFN79

5 reports from 2018 to 2023

• Chordate Medical Holding AB 2023 Annual Report
• Chordate Medical Holding AB 2022 Annual Report and Consolidated Financial Statements
• Chordate Medical Holding AB 2021 Annual Report and Consolidated Financial Statements
• Chordate Medical Holding AB 2020 Annual Report and Consolidated Financial Statements
• Chordate Medical Holding AB 2018 Annual Report and Consolidated Financial Statements